LIQUIDIA CORPORATION

LQDA ·Healthcare, Drug Manufacturers - General, United States
Financial Statements Income Statement
Annual Quarterly

Income Statement

Line Item Aug 2024 Jun 2024 May 2024 Mar 2024 Mar 2024 Dec 2023 Nov 2023 Sep 2023
Revenue $3.7M $3.0M $4.5M $3.7M
Cost of Revenue $1.5M $1.5M $570.0K
Gross Profit $2.2M $1.5M $3.1M
Gross Margin 59.2% 50.6% 84.5%
Operating Expenses
Research & Development $9.4M $10.1M $7.4M
SG&A Expense $19.9M $20.2M $10.6M
Operating Income $-27.2M $-28.8M $-26.4M $-14.9M
Operating Margin -743.3% -969.1% -583.4% -404.9%
Interest Expense $2.6M $2.5M $1.8M
Pretax Income
Income Tax Expense
Net Income $-28.7M $-30.1M $-27.5M $-15.8M
Net Margin -783.5% -1,012.2% -605.8% -429.3%
EPS (Basic) $-0.38 $-0.40 $-0.43 $-0.24
EPS (Diluted) $-0.38 $-0.40 $-0.43 $-0.24
Shares Outstanding (Basic) 76.8M 76.4M 76.4M 75.4M 76.0M 68.6M 64.9M 64.9M
Shares Outstanding (Diluted) 76.8M 76.4M 76.4M 75.4M 76.0M 68.6M 64.9M 64.9M
Dividends Per Share
← Newer Page 3 of 7 Older →